EUVIMEDEUVIMED entdecken
Crossref

Development and Validation of HPLC Method for Estimation of Ibandronic Acid in Tablet Dosage Form

Sukalyan Kumar Kundu

Journal of Pharmaceutical Research and Innovation · 2024

DOI: 10.36647/jpri/04.02.a002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Research and Innovation, 2024. Verfasst von Sukalyan Kumar Kundu.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ibandronic acid is a highly efficacious bisphosphonate that effectively impedes the process of osteoclast-mediated bone resorption in postmenopausal women with osteoporosis. Our investigation aimed to establish a cost-effective high-performance liquid chromatography (HPLC) method for the accurate and dependable quantification of Ibandronic Acid. It is imperative to note that this particular compound is not included in the official pharmacopoeial compendium. Employing a C18 column (Hypersil BDS recommended), the compound was isolated utilizing a mobile phase containing pentanesulfonic acid sodium salt, EDTA, TEA, and orthophosphoric acid. The flow rate was set at 1 mL/min, with detection wavelength at 200 nm. Employing a calibration curve, the amount of Ibandronic acid present in tablet form was determined. The methodology expounded in this research was validated in compliance with the International Council for Harmonisation (ICH) guidelines for various parameters, encompassing linearity, accuracy, precision, robustness, and specificity. The linearity of concentrations, specifically at 0.19, 0.32, 0.51, 0.64, 0.76, and 0.96 mg/mL, exhibited a strong correlation coefficient (r) of 0.999. Ibandronic Acid displayed a retention time of 4.58 ± 0.45 min. The specificity assessment indicated the absence of impurities. The Limits of Detection (LOD) and quantification (LOQ) values were determined to be 0.021026880 and 0.06371782, respectively. This methodology can be effectively utilized for routine quality control evaluation in the analysis of Ibandronic Acid in tablet preparations.

Zitieren

APA

Kundu, S. K. (2024). Development and Validation of HPLC Method for Estimation of Ibandronic Acid in Tablet Dosage Form. Journal of Pharmaceutical Research and Innovation. https://doi.org/10.36647/jpri/04.02.a002

Vancouver

Kundu SK. Development and Validation of HPLC Method for Estimation of Ibandronic Acid in Tablet Dosage Form. Journal of Pharmaceutical Research and Innovation. 2024. doi:10.36647/jpri/04.02.a002

BibTeX
@article{Kundu2024,
  author = {Kundu, Sukalyan Kumar},
  title = {Development and Validation of HPLC Method for Estimation of Ibandronic Acid in Tablet Dosage Form},
  journal = {Journal of Pharmaceutical Research and Innovation},
  year = {2024},
  doi = {10.36647/jpri/04.02.a002}
}
Kostenlos starten →